angiotensin II receptor inhibitors in hypertension
Last reviewed 02/2023
- the principal mechanism in which angiotensin II receptor inhibitors lower blood pressure is probably inhibition of angiotensin-mediated vasoconstriction
- the antihypertensive efficacy of angiotensin II receptor inhibitors appears to be equal to that of atenolol or ACE inhibitors
- angiotensin II receptor inhibitors and thiazide diuretics may be combined, resulting in additive hypotensive effects; an additive effect also occurs if angiotensin II receptor inhibitors are used with beta blockers
- the combination of an ACE inhibitor and an angiotensin II receptor antagonist is not recommended (1)
- angiotensin II receptor inhibitors have a gradual onset of action and adverse effects such as first dose hypotension are rare
- the
ACD strategy for hypertension management suggests an ACE inhibitor (or angiotensin
II inhibitor) as first-line therapy for younger (non-black) patients
- the VALUE trial compared the use of valsartan to amlodipine in the management of hypertension (see linked item)
Reference:
- Prescribers' Journal (1999);39 (1): 24-30.
- J Hum Hypertens. 2003 Feb;17(2):81-6.
angiotensin II receptor antagonists
Valsartan Anti-hypertensive Long-term Use Evaluation (VALUE)